undefined

Dedicated Staff

Clinical Research Coordination Team

Aurélie Fischer

undefined

 

 

 

💡

📌
 

📞

📧

 

 

Clinical Research Coordinator

1A-B, rue Thomas Edison
L-1445 Strassen

+352 26970-230

Aurelie.Fischer@lih.lu

Biography

Aurélie Fischer integrated the LIH in August 2001 as a Research Engineer in the HIV Clinical & Translational Research Unit and joined the CIEC team in 2014 as a Clinical Research Coordinator. These experiences allowed her to obtain a strong know-how both at the scientific and the administrative level of clinical research. Her main role is to coordinate research projects from the early phase until the closing of the project, in collaboration with the Clinical Research Associate and the support services of LIH. In particular, she centralizes and manages the new project feasibilities (feasibility of the project idea and support to protocol writing, budget evaluation and negotiation, contact with potential partners...) of external sponsors, but also of the researchers from the LIH. She also participates to the development of the unit by identifying new potential collaborations or research opportunities and by increasing the visibility of CIEC.

Main activities

• In collaboration with the ministry of health: Point Prevalence Survey in healthcare-associated infections, support to quality procedure writing and reviewing
• Support to projects in several research area: medical device, infectious diseases, oncology etc
• Visibility actions : organization/participation to events to sensitize the general public and the young public to clinical research and public health issues (World AIDS day, Medical Research day, Researchers at school), presentations at scientific conferences, writing of articles (SEMPER journal)

 

Jonathan Cimino, PhD

undefined

 

 

 

💡

📌
 

📞

📧

 

 

Clinical Research Coordinator - Ecrin European Correspondent

1A-B, rue Thomas Edison
L-1445 Strassen

+352 26970-947

Jonathan.Cimino@lih.lu

Biography

Dr. Jonathan Cimino received a PhD in Biomedical and Pharmaceutical Sciences in 2015 at the University of Liège (Belgium) in cancer field. Dr. Jonathan Cimino has helped to understand the resistance of cancer cells to antiangiogenic therapies. He received several grants and did a training in cancer research related to the “Advanced Multimodality Image Guided Operating” (AMIGO) for clinical purposes at Harvard Medical School. Then, he hold a postdoctoral/project leader position at GIGA-Cancer. After that, he worked for a contract research organization (CRO) in the field of clinical research as clinical project leader. Dr. Jonathan Cimino joined the Luxembourg Institute of Health (LIH) in November 2017. As Coordinator, Dr. Jonathan Cimino is mainly involved in designing the Luxembourg Centre for Clinical and Translational Research and is responsible for full early development and coordination of clinical research projects. 
As European correspondent for the academic network of clinical trials (ECRIN), he also provides advice in the fields of regulatory, ethics and logistics to European investigators wishing to extend their academic clinical trials in Luxembourg or Belgium. He coordinates the activities of the monitors and is responsible for the overall management of the projects internationally and at the country level. He actively participates in European consortia and grant applications. His responsibilities also include the development of the unit (in close collaboration with the Head of Unit) through regular contacts with the different clinical research actors (Hospitals, Authorities, pharmaceutical companies, IBBL…). 

Main activities

• Coordination of set-up activities of the new LCTR
• European correspondent for the academic network of clinical trials (ECRIN) for Luxembourg and Belgium
• Early development of clinical trial and coordination of academics and private projects
• Support for the promotion, development and strategy of the CIEC

Current ECRIN projects

• HIVACAR (Infectious disease, HIV vaccine): A phase IIa, multicentre, randomized, double-blinded placebo controlled trial to evaluate the safety and tolerability of the combination of a therapeutic vaccine (MVA-B, iHIVARNA01.3 or HIVACAR01) plus 3BNC117 bNAb with romidepsin
• PrOOf (Neurology, Intensive Care Unit): Penumbral Rescue by Normobaric O=O Administration in Patients with Acute Ischemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial (PrOOf)
• OTBB3 (Pediatry, rare disease): Oxytocin treatment in neonates and infants (babies) with Prader-Willi syndrome: effects of intranasal administrations of oxytocin in infants aged from 0 to 3 months vs placebo on sucking and swallowing
• ImmunAID (Rhumatology): Immunome project consortium for AutoInflammatory Disorders
• BETA3 (Cardiology, heart insufficiency): A multicentre, randomised, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease
• POPART: PROPHYLACTIC OROPHARYNGEAL SURFACTANT FOR PRETERM INFANTS: A RANDOMISED TRIAL: A randomised trial of oropharyngeal surfactant versus no intervention at birth for infants born before 29 weeks of gestation to prevent endotracheal intubation for respiratory failure in the first 5 days of life

More information about ECRIN

 

 

↩ī¸ Back to the team